Relmada Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.

About RLMD

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications.

CEO

Sergio Traversa

CEOSergio Traversa

Employees

Employees17

Headquarters

Coral Gables, Florida

HeadquartersCoral Gables, Florida

Founded

2012

Founded2012

Employees

Employees17

RLMD Key Statistics

Market cap

53.11M

Market cap53.11M

Price-Earnings ratio

-0.72

Price-Earnings ratio-0.72

Dividend yield

—

Dividend yield—

Average volume

2.96M

Average volume2.96M

High today

$1.61

High today$1.61

Low today

$1.46

Low today$1.46

Open price

$1.52

Open price$1.52

Volume

425.43K

Volume425.43K

52 Week high

$3.98

52 Week high$3.98

52 Week low

$0.2404

52 Week low$0.2404

RLMD News

TipRanks 3d

Relmada Therapeutics Highlights Strategic Progress to Shareholders

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 3d

Relmada Therapeutics CEO remains ‘optimistic’ about company’s future

In a letter to shareholders, CEO Sergio Traversa said, “2025 has been a truly transformational year for Relmada Therapeutics (RLMD). With the year now well into...

People also own

Based on the portfolios of people who own RLMD. This list is generated using Robinhood data, and it’s not a recommendation.